What Caused The Madrigal Pharmaceuticals (MDGL) Stock To Rise In Pre-Market Trades?
The clinical-stage biopharmaceutical firm Madrigal Pharmaceuticals Inc. (Nasdaq: MDGL) has increased 211.13% to $198.50 in pre-market trading on the most recent Monday after announcing topline